Chromadex

ChromaDex keeps foot on sales & research pedal even as stubborn losses persist

13-May-2022 By Hank Schultz

Branded ingredient supplier ChromaDex announced an 18% sales gain in a recent earrings report. A continued push to increase the science behind its TruNiagen brand is part of the reason, the company’s co-founder said.

ChromaDex Sr VP: ‘We’re happy for our external research program to serve as a model for industry’

25-Apr-2022 By Stephen Daniells

As the ChromaDex External Research Program passes a significant milestone with 250 material transfer agreements (MTAs), are there lessons for the rest of the industry to learn about building out R&D programs?

NutraWomen Wednesday: Yasmeen Nkrumah-Elie, PhD, Global Director of External Research, ChromaDex

06-Apr-2022 By Danielle Masterson

Yasmeen Nkrumah-Elie, PhD, oversees external Research, managing a portfolio of over 200 studies, as well as supporting marketing, regulatory, and scientific affairs projects. The Global Director of External Research for ChromaDex has over 13 years of...

ChromaDex announces Tru Niagen to be available in 3,000 Walmart stores

10-Mar-2021 By Stephen Daniells

ChromaDex has announced its first major retailer deal for its NAD+ booster Tru Niagen, with the product set to be available in 3,000 Walmart stores across the U.S. beginning in June 2021.

Healthy Ageing APAC Summit 2019

Chronological vs biological’: Chromadex aims to use personalised nutrition as means to revolutionise ageing

13-Aug-2019 By Tingmin Koe

Personalised nutrition and other specific therapeutic functions with a focus on changing the concept of ageing are the way forward for ChromaDex’s flagship nicotinamide riboside (NR) supplement, said the firm.

Tru Niagen’s Canadian retail footprint now includes Whole Foods in Ontario

24-Jul-2019 By Adi Menayang

ChromaDex Corp., the California-based maker of nicotinamide riboside supplement Tru Niagen, expands its Canadian retail footprint to include all seven Whole Foods Markets in the province of Ontario.

People on the move: ChromaDex, Deerland, BrandHive, and more

15-Aug-2018 By Adi Menayang

New chief officers, presidents, directors, managers and more—here’s a cheat-sheet of who’s who and what’s new in the dietary supplements and natural products industry this summer.

Notes from Nutrition 2018 in Boston

The 'anti-aging' ingredient: Get to know nicotinamide riboside

15-Jun-2018 By Adi Menayang

Brands and suppliers are touting nicotinamide riboside (NR), a form of vitamin B3, as an 'anti-aging' ingredient. What validates it for that use?

Jaksch says move into chairman role part of ChromaDex's pivot toward finished goods

14-May-2018 By Hank Schultz

A strategic pivot toward finished products underpins his impending move toward an advisory role, said ChromaDex CEO Frank Jaksch.

Online opportunities — not loss of big account — drove finished products shift, ChromaDex CEO claims

21-Aug-2017 By Hank Schultz

A shift in market dynamics — not a legal dispute with a key customer — is what drove ChromaDex to try for a second time the finished products route for one of its branded ingredients.

ChromaDex moves forward with transformation to finished goods brand

11-Aug-2017 By Hank Schultz

ChromaDex is making progress on a transformation to a finished goods company based on its Niagen ingredient even as it struggles with continuing losses to shareholders.

Marketer writes down remaining BluScience inventory, pivots toward ChromaDex's PurEnergy ingredient

02-May-2016 By Hank Schultz

Canadian supplement company NeutriSci has now dropped all sales of ChromaDex’s pTeroPure ingredient in favor of an energy product line based upon its PurEnergy ingredient, which is a pTeroPure/caffeine co crystal.

ChromaDex revenue hits record as ingredient sales bring company close to profitability

17-Aug-2015 By Hank Schultz

Branded dietary ingredient supplier ChromaDex reported record revenue in its second quarter 2015 earnings statement. It was the fifth consecutive quarter in which the company reached a new earnings plateau.

ChromaDex builds potential anti-aging action of Niagen with first human data

17-Feb-2015 By Stephen DANIELLS

A single dose of nicotinamide riboside (NR) may significantly increases levels of NAD+, which is key to cellular energy metabolism and mitochondrial function, says a new study with healthy human volunteers using ChromaDex’s Niagen NR.

ChromaDex bolsters IP protection around pTeroPure with memory, sun damage patents

26-Nov-2014 By Hank Schultz

ChromaDex has bolstered the IP protection around pTeroPure, one of its branded ingredients, with the announcement of two patents relating to pterostilbene, which are the second and third patents granted to the company on the ingredient.

DSM Venturing strategically invests in ChromaDex

21-Oct-2013 By Stephen DANIELLS

Chromadex has received equity financing from DSM Venturing, the corporate venture arm of Royal DSM, a move that will allow the Californian company to explore new topics and to accelerate its existing pipeline.

ChromaDex cuts losses while posting tiny revenue increase

14-Aug-2013 By Hank Schultz

ChromaDex Corporation reported a 1% rise in overall revenues in the second quarter of 2013 while cutting losses to under $1 million.

HPN's new product with Chromadex’s Niagen targets neuroprotection for contact sports

27-Jun-2013 By Stephen DANIELLS

The first product containing Chromadex’s Niagen-branded nicotinamide riboside ingredient is being launched by High Performance Nutrition (HPN) to support neuroprotection in contact sports.

ChromaDex launches caffeine/pterostilbene ingredient, releases year-end financials

01-Apr-2013 By Hank Schultz

ChromaDex Corp. today announced the introduction of a new ingredient, called PURENERGY, which is a patented co-crystal ingredient comprised of caffeine and the company’s synthetic pterostilbene ingredient pTeroPure. The announcement comes on the heels...